Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004826998 | SCV005459256 | uncertain significance | not specified | 2024-11-25 | criteria provided, single submitter | clinical testing | The c.2110G>A (p.E704K) alteration is located in exon 5 (coding exon 5) of the NLRP13 gene. This alteration results from a G to A substitution at nucleotide position 2110, causing the glutamic acid (E) at amino acid position 704 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |